Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-03

Clinical Trial Update: Study of Suramin in Subjects With Furosemide-Resistant AKI [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of suramin in subjects with furosemide-resistant acute kidney injury is ongoing; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Suramin (suramin)

Snippet

Sponsor: Rediscovery Life Sciences | Conditions: Acute Kidney Injury | Phase 2 | Status: UNKNOWN